Skip to main content
Veterinary Medicines

SEMELCEF 200 mg tablets for dogs and cats

Authorised
  • Cefadroxil monohydrate

Product identification

Medicine name:
SEMELCEF 200 mg tablets for dogs and cats
Semelcef 200 mg Tablet
Semelcef 200 mg Comprimé
Semelcef 200 mg Tablette
Active substance:
  • Cefadroxil monohydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefadroxil monohydrate
    210.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB05
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • box containing 10 blisters of 10 tablets (100 tablets)
  • box containing 1 blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V545306
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0304/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Greece
  • Hungary
  • Ireland
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

English (PDF)
Published on: 25/12/2023
Download
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022
German (PDF)
Published on: 22/03/2022

Summary of Product Characteristics

English (PDF)
Published on: 25/12/2023
Download
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022

Labelling

English (PDF)
Published on: 25/12/2023
Download

eu-PUAR-esv0304001-dcp-semelcef-200-mg-tablets-for-dogs-and-cats-en.pdf

English (PDF)
Published on: 25/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."